Search Results - ami+shah

3 Results Sort By:
Development of a Personalized, Interactive Visualization Tool to Improve Risk Prediction and Clinical Care in Scleroderma
Unmet NeedAccording to the Scleroderma Foundation, it is estimated that 300,000 people in the United States are living with scleroderma. Scleroderma is a disease that may affect many organs of the body and is characterized by progressive fibrosis, vascular disease and immunological derangements. Scleroderma is highly variable in clinical phenotype,...
Published: 6/21/2024   |   Inventor(s): Ami Shah, Ji Soo Kim, Scott Zeger, Laura Hummers, John Scott
Keywords(s):  
Category(s): Copyright, Technology Classifications > Computers, Electronics & Software, Technology Classifications > Computers, Electronics & Software > Healthcare IT
Screening Method to Identify Scleroderma Immune Responses with Anti-cancer Activity, and Induction of such Immune Responses for Cancer Therapy
Unmet NeedEpidemiological studies have shown that patients with scleroderma, a type of autoimmune rheumatic disease affecting the skin and connective tissues, have an increased risk of developing cancer relative to the general population. The exact etiology of scleroderma is still unknown. The Scleroderma Foundation estimates about 100,000 to 300,000...
Published: 6/20/2024   |   Inventor(s): Ami Shah, Livia Casciola-Rosen, Antony Rosen, Takeru Igusa, Marikki Laiho
Keywords(s): Antibodies, Autoimmune Diseases, Biologics, Biomarker, Cancers, Clinical Diagnostics, Diagnostic Biomarker, Disease Indication, In Vitro Diagnostics, Inflammatory Disorders, Risk Stratification, Scleroderma, Skin Disorders, Skin Fibrosis, Therapeutic Matter, Therapeutic Substance, Therapeutics
Category(s): Clinical and Disease Specializations, Clinical and Disease Specializations > Oncology, Clinical and Disease Specializations > Autoimmunity, Clinical and Disease Specializations > Fibrosis, Clinical and Disease Specializations > Rare Diseases, Clinical and Disease Specializations > Inflammation, Clinical and Disease Specializations > Immunology, Technology Classifications > Diagnostics > Biomarkers, Technology Classifications > Diagnostics > In Vitro Diagnostics, Technology Classifications > Computers, Electronics & Software > Precision Medicine Tools, Technology Classifications > Diagnostics > Diagnostic Biomarkers, Technology Classifications > Therapeutic Modalities > Biologics, Technology Classifications > Therapeutic Modalities > Antibodies, Technology Classifications > Therapeutic Modalities > Targets, Technology Classifications > Computers, Electronics & Software, Clinical and Disease Specializations > Dermatology, Technology Classifications > Diagnostics, Technology Classifications > Therapeutic Modalities, Clinical and Disease Specializations > Dermatology > Scleroderma
Autoimmunity-based Peptides as Cancer Vaccines
Autoimmunity-based Peptides as Cancer Vaccines JHU REF: C12807 Invention novelty: This technology uses autoantigen-derived peptides as novel immunotherapy to prevent and treat cancer. Value Proposition: Today, millions of people are living with cancer or have had cancer. Despite significant advances in cancer diagnosis and treatment over the...
Published: 6/20/2024   |   Inventor(s): Erika Darrah, Christine Joseph, Kenneth Kinzler, Livia Casciola-Rosen, Nickolas Papadopoulos, Ami Shah, Antony Rosen, Bert Vogelstein
Keywords(s): Antigens, Biologics, Cancers, Disease Indication, Immunotherapy, Single, Therapeutic Matter, Therapeutic Substance, Therapeutics, Therapy Type, Vaccine
Category(s): Clinical and Disease Specializations, Clinical and Disease Specializations > Oncology, Technology Classifications > Therapeutic Modalities, Technology Classifications > Therapeutic Modalities > Biologics, Technology Classifications > Therapeutic Modalities > Immunotherapies, Technology Classifications > Therapeutic Modalities > Vaccines
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by Inteum